Drug Shortage Report for ACT CELECOXIB

Last updated on 2021-02-12 History
Report ID 132291
Drug Identification Number 02420163
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB 200MG CAP
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) CELECOXIB
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-20
Estimated end date
Actual end date 2021-02-05
Shortage status Resolved
Updated date 2021-02-12
Company comments Item is Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-12 French Compare
v3 2021-02-12 English Compare
v2 2021-01-22 French Compare
v1 2021-01-22 English Compare

Showing 1 to 4 of 4